CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

GLP-1 drugs like Ozempic may have much more serious, and even potentially deadly, side effects than originally thought.

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.